Oncology & Cancer
Experimental drug trial seeks to improve treatment for lymphoma
Patients with a common type of fast-growing cancer are being given fresh hope in a new clinical trial.
Aug 11, 2017
0
4
Lymphoma
Oncology & Cancer
Using miRNA to cure mature B cell neoplasia
Almost half of patients with mature B cell neoplasia are faced with the ineffectiveness of existing treatments. However, they may soon benefit from new therapeutic tools relying on miRNA—a small non-coding RNA molecule ...
Aug 9, 2017
0
0
Oncology & Cancer
Breakthrough in reversing treatment resistance in blood cancer patients
Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.
Jul 14, 2017
0
1
Oncology & Cancer
The gene behind follicular lymphoma
Follicular lymphoma is an incurable cancer that affects over 200,000 people worldwide every year. A form of non-Hodgkin lymphoma, follicular lymphoma develops when the body starts making abnormal B-cells, which are white ...
Jun 28, 2017
0
31
Oncology & Cancer
Cancer researchers look at resistance to targeted therapy in mantle cell lymphoma
Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called Ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment. ...
Jun 14, 2017
0
18
Cardiology
Hodgkin lymphoma survivors have more severe coronary artery disease post chest irradiation
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
May 8, 2017
0
0
Oncology & Cancer
Diversity key to better lymphoma immune response
A University of Queensland researcher has found patients with non-hodgkins lymphoma are most likely to survive if they have a rich variety of T-cells.
Apr 3, 2017
0
51
Oncology & Cancer
Hodgkin lymphoma survivors at high risk of second cancers
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.
Mar 13, 2017
0
0
Diseases, Conditions, Syndromes
Gluten contributes to the development of rare, deadly blood cancer in a small group of coeliac patients
Scientists in The Netherlands have revealed how gluten plays a role in the development of a rare form of cancer, for some people with coeliac disease.
Feb 28, 2017
0
76
Oncology & Cancer
New drug cocktail unlocks potential of new leukemia treatment
A new combination of drugs, tested by University of Manchester scientists, has significantly enhanced the survival of laboratory mice with lymphoma.
Jan 23, 2017
0
22
